Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
What Is Breast Cancer? Types, Causes & Treatment.
What Is Breast Cancer? Types, Causes & Treatment. 4

Breast cancer is a complex disease where abnormal cells grow out of control. This can lead to tumors. The breast cancer scientific name is used to describe this malignancy. It’s important to know the different types of breast cancer when dealing with a diagnosis.

We aim to give you a clear understanding of this illness. Our goal is to support you as you make informed medical decisions.

Key Takeaways

  • Breast malignancy involves the uncontrolled growth of abnormal cells in the body.
  • Identifying the specific biological variant is vital for creating a successful care plan.
  • We prioritize patient education to empower your medical choices.
  • Early detection significantly improves long-term health outcomes for women.
  • Our specialists provide complete support throughout every stage of your recovery.

Understanding Breast Cancer and Current Statistics

Understanding Breast Cancer and Current Statistics
What Is Breast Cancer? Types, Causes & Treatment. 5

Understanding breast cancer starts with knowing how common it is worldwide. We see knowledge as a foundational tool for those facing this disease. By looking at current data, we can get ready for better care and make informed choices.

The Global Impact of Breast Cancer

Breast cancer is a big health problem worldwide. It affects millions of people and their families every year. In the U.S., it’s expected that about 321,910 women will be diagnosed with invasive breast cancer in 2024-2025.

This high number shows we need better support and medical care. We make sure our patients get the best diagnostic tools. Knowing these numbers helps us fight for better health everywhere.

Survival Rates and the Power of Early Detection

Modern medicine has made a big difference in fighting cancer. Finding breast cancer early means a survival rate over 99 percent. This shows how important regular check-ups and screenings are.

For breast cancer found at different stages, the survival rate is 91 percent. We stress the importance of taking care of your health early. Our team works hard to catch cancer early for better lives.

Detection StageFive-Year Survival RateClinical Focus
LocalizedOver 99%Routine Screening
Regional86%Advanced Imaging
Distant31%Systemic Therapy

Exploring the Different Types of Breast Cancer

Exploring the Different Types of Breast Cancer
What Is Breast Cancer? Types, Causes & Treatment. 6

We believe that knowledge is key to effective care, when dealing with breast malignancy types. Knowing the type of breast cancer you have is the first step. It helps in creating a treatment plan that fits your health needs.

Invasive Ductal and Lobular Carcinomas

When people ask about breast cancer types, we often talk about the most common ones. Invasive ductal carcinoma is the most common, making up most diagnoses. It starts in the milk ducts and grows into the surrounding tissue.

Invasive lobular carcinoma is another common type. It begins in the milk-producing glands, or lobules. Each type needs a specific treatment plan for the best results.

Non-Invasive Variants: Ductal Carcinoma in Situ

Not all breast cancers are the same. Ductal carcinoma in situ (DCIS) is a non-invasive type. It has abnormal cells in the milk duct lining but hasn’t spread.

DCIS is treatable, but it needs careful monitoring and medical care. We classify these types to ensure each patient gets the right care.

Molecular Subtypes: Triple-Negative and HER2-Positive

Modern medicine lets us study the disease’s biology deeply. Advanced molecular testing helps us find specific types of breast cancer. This guides our treatment plan.

Key molecular subtypes include:

  • HER2-positive breast cancer: This type has the HER2 protein, leading to fast-growing cancer cells.
  • Triple-negative breast cancer: This is aggressive because it lacks three common receptors for treatment.

We aim to explain these complex types simply. Identifying these breast cancers types early helps us offer the best care for you.

Risk Factors and Modern Treatment Approaches

The fight against breast cancer is ongoing, and we’re committed to leading the way with care. We believe that empowering patients with knowledge is key to effective treatment and wellness.

Identifying Primary Risk Factors

Many wonder what causes breast cancer. Factors like age, family history, and reproductive history are important. But, some people get breast cancer without any clear risk factors.

We suggest focusing on what you can control, like regular check-ups and a healthy lifestyle. Knowing your health history helps us create a preventative strategy just for you. You’re not alone, and we’re here to help every step of the way.

Current Trends in Breast Cancer Incidence

Recent data shows a 1 percent annual rise in breast cancer from 2012 to 2021. This increase is mainly due to more hormone receptor-positive localized disease. Though these numbers might worry you, they also show we’re catching cancers earlier than ever.

Early detection is our strongest tool for better outcomes. By understanding these trends, we can improve our screening methods. This ensures patients get the best timely and accurate treatments today.

Standard Treatment Modalities

We use a team approach to treat breast cancer. This includes surgery, radiation, and targeted therapies. Our goal is to fight the disease hard while also caring for your quality of life.

The table below shows the main treatments we use for our patients:

Treatment TypePrimary GoalPatient Benefit
Surgical OncologyTumor removalLocal control of disease
Radiation TherapyEliminate residual cellsReduced recurrence risk
Biological TherapyTarget specific receptorsPersonalized, precise care

We offer full support to help you understand and navigate your treatment. Our team is here to make sure you feel informed, respected, and cared for on your journey to recovery.

Conclusion

Getting a breast cancer diagnosis can be tough. It needs clear info and a strong support team. We hope this guide helps you understand the disease better.

Knowing about breast cancer and its types is key. Early detection is also very important. It can really help your chances of beating it.

Start taking care of your health by being aware and getting screened. Being informed is a big step towards a healthier future. Small steps today can lead to big changes later.

At Medical organization and MD Anderson Cancer Center, we’re all about top-notch care. We know how tough this journey can be. We’re here to support you every step of the way.

If you have more questions or need help, don’t hesitate to reach out. Our team is ready to help you make informed decisions. We’ll guide you with care and expertise.

FAQ’s:

How many types of breast cancer are there and how are they classified?

Breast cancer is classified based on where it starts and how it behaves. It includes types like ductal, lobular, and rarer inflammatory or Paget’s disease.

What is the most common type of breast cancer diagnosed today?

The most common type is invasive ductal carcinoma. It starts in the milk ducts and spreads into surrounding breast tissue.

What are considered the most aggressive breast cancer types?

Inflammatory breast cancer and triple-negative breast cancer are among the most aggressive types. They tend to grow quickly and spread earlier.

What is the survival rate for different types of breast cancer?

Survival rates vary depending on type, stage, and treatment response. Early-stage cancers have much higher survival rates than advanced or aggressive forms.

Why is the incidence of certain breast cancers rising?

Rising incidence is linked to better screening, aging populations, lifestyle factors, and hormonal influences. More detection through mammography also increases reported cases.

Are there specific risk factors for these different kinds of breast cancer?

Yes, risk factors vary but include genetics, hormone exposure, age, and lifestyle. Some types are also linked to specific gene mutations like BRCA1 and BRCA2.

 References:

 National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/31513381/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 83